They could be used as novel therapeutic targets for hypertensive stroke patients by breaking the vicious cycle of oxidative stress, inflammation, and hypertension by inducing the production of NEAT1 and GAS5 while silencing HOTAIR could be a new therapeutic and preventive strategy aiding in the treatment of hypertension and preventing stroke formation in hypertensive patients. This evidence concerns the gene HOTAIR and Stroke.